Finally, many novel genes such as C5AR1, KRT80, FRMD6, OLFML2B, PRRX1 and ZNF532 are included, suggesting that CRC-113 gene signature contains new promising biomarkers for CRC diagnosis and potential therapeutic targets. The gene discussed is FRMD6; the disease is colorectal carcinoma.